A Jin Ten Data News, a Fushen Pharmaceutical, announced in the evening of November 7 that the company plans to accelerate the expansion of the market for microbial protein business. The company intends to invest in the establishment of Fushen Microbial Protein Application Consumer Product Development and Sales Subsidiaries in Shanghai and Singapore, with registered capital of not more than 10 million yuan and 3 million Singapore dollars, respectively.
Ver original
Esta página pode conter conteúdos de terceiros, que são fornecidos apenas para fins informativos (sem representações/garantias) e não devem ser considerados como uma aprovação dos seus pontos de vista pela Gate, nem como aconselhamento financeiro ou profissional. Consulte a Declaração de exoneração de responsabilidade para obter mais informações.
Fuxiang Pharmaceutical: planos para criar subsidiárias em Xangai e Singapura para expandir o negócio de proteínas microbianas
A Jin Ten Data News, a Fushen Pharmaceutical, announced in the evening of November 7 that the company plans to accelerate the expansion of the market for microbial protein business. The company intends to invest in the establishment of Fushen Microbial Protein Application Consumer Product Development and Sales Subsidiaries in Shanghai and Singapore, with registered capital of not more than 10 million yuan and 3 million Singapore dollars, respectively.